Pharmacy Technician Calculations Review
(Cadillac A-B, Level 5)
Knowledge-type Activity
112-000-12-144-L04-P & 112-000-12-844-L04-T, 1.3 contact hours
Simon Kue, Pharm.D., associate professor of pharmacy practice, Lansing Community College, Lansing, Mich.
At the end of this presentation, participants should be able to recall a method for performing total parenteral nutrition calculation orders; interpret common roman numerals in prescriptions; and define percentage strength for various mixtures and solve problems. Participants should also be able to define ratio strength for pharmaceutical products and solve problems; reproduce calculations necessary to determine quantity dispenses, dosage and days supply for prescriptions; and recall intravenous flow rate.

The Skinny on Obesity Medications: What’s Here and What’s Coming
(Ambassador Ballroom 1, Level 3)
Knowledge-type Activity
112-000-12-145-L01-P & 112-000-12-845-L01-T, 1.3 contact hours
Jill Covyeou, Pharm.D., assistant professor, Ferris State University College of Pharmacy, Essexville, Mich.
At the end of this presentation, participants should be able to outline a weight-loss option based on patient characteristics; provide safety and efficacy data to patients, depending on medication used for weight loss; and identify safety concerns associated with common over-the-counter weight-loss medications.

2012 Pharmacy Law – Controlled Substance Review, Part 1
(Ambassador Ballroom 1, Level 3)
Knowledge-type Activity
112-000-12-146-L03-P & 112-000-12-846-L03-T, 1.3 contact hours
Gregory J. Baran, R.Ph., director of governmental affairs, Michigan Pharmacists Association, Lansing, Mich.
At the end of this presentation, participants should be able to discuss the new federal regulations related to controlled substances; explain the variations between state and federal regulations; and discuss the restrictions on the implementation of electronic prescriptions for controlled substances. (This program meets pharmacy law requirements for certified pharmacy technicians.) Sponsored by CVS Pharmacy.

Pharmacology Meets Practice: Update on
New Antithrombotics and Drugs of Calcium Homeostasis
(Cadillac A-B, Level 5)
Knowledge-type Activity
112-000-12-147-L01-P & 112-000-12-847-L01-T, 1.3 contact hours
Justine S. Gortney, Pharm.D., assistant professor, Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences, and clinical pharmacy specialist for internal medicine, Detroit Receiving Hospital, Detroit, Mich.; and Joshua N. Raub, Pharm.D., clinical pharmacy specialist for internal medicine, Detroit Receiving Hospital, Detroit, Mich.
At the end of this presentation, participants should be able to discuss the relationship of the clotting cascade and vascular damage resulting in thrombosis in order to understand the pharmacology of new and current antithrombotic products on the market. Participants should also be able to explain calcium homeostasis in the body, including the relationships of vitamin D metabolism, calcium, prosphorus and parathyroid hormone and relate it to the pharmacology of existing drugs and dietary supplements that affect it; provide vitamin D recommendations for the general public, patients with vitamin D deficiency and renal disease; and review the place in therapy of these same antithrombotics and drugs affecting calcium homeostasis in related disease states, including selection of patients, disease treatment, duration and patient counseling points.

House of Delegates Session
2012 Pharmacy Legislative and Regulatory Trends
(Ambassador Ballrooms 2-3, Level 3)
Knowledge-type Activity
112-000-12-148-L03-P & 112-000-12-848-L03-T
Harvey Schmidt, chairman, Michigan Board of Pharmacy, Tecumseh, Mich.; and Larry D. Wagenknecht, chief executive officer, Michigan Pharmacists Association, Lansing, Mich.
At the end of this presentation, participants should be able to discuss proposed state and federal legislation; discuss the impact of the Board of Pharmacy rule changes on the practice of pharmacy; explain how legislation may impact the profession; and discuss recent actions taken against pharmacists by the Board of Pharmacy. (This program meets pharmacy law requirements for certified pharmacy technicians.)

2012 Pharmacy Law – State of Michigan, Part 2
(Ambassador Ballroom 1, Level 3)
Knowledge-type Activity
112-000-12-149-L03-P & 112-000-12-849-L03-T, 1.3 contact hours
Gregory J. Baran, R.Ph., director of governmental affairs, Michigan Pharmacists Association, Lansing, Mich.
At the end of this presentation, participants should be able to discuss the most recent changes in the Public Health Code; discuss new federal regulations regarding “agent of the prescriber;” and explain the impact that the changes and new regulations will have on the practice of pharmacy. (This program meets pharmacy law requirements for certified pharmacy technicians.) Sponsored by CVS Pharmacy.

How Pharmacies Fit Into the Patient-Centered Medical Home
(Cadillac A-B, Level 5)
Knowledge-type Activity
112-000-12-150-L04-P & 112-000-12-850-L04-T, 1.3 contact hours
Helen Berlie, Pharm.D., clinical assistant professor, Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences, and ambulatory care specialist, Health Centers Detroit, Detroit, Mich.; Natalie Pirkola, Pharm.D., clinical pharmacist, Administrative Network, Inc. and Oakland Southfield Physicians, PC, Warren, Mich.; Karin Proos, Pharm.D., director of pharmacy, Spectrum Health Medical Group – Physicians, Grand Rapids, Mich.; and Christopher Smith, R.Ph., pharmacy services manager, Spartan Stores, Ada, Mich.
At the end of this presentation, participants should be able to describe the patient-centered medical home (PCMH) model; identify opportunities within the practice sites for pharmacist involvement and interaction; and discuss reimbursement strategies for practicing within the PCMH. Participants should also be able to identify resources and references to utilize for PCMH practices; and describe the rules and regulations that pertain to practice in the PCMH.

Oh, How My Head Aches! (Ambassador Ballroom 1, Level 3)
Knowledge-type Activity
112-000-12-152-L01-P & 112-000-12-852-L01-T, 1.3 contact hours
James M. Lile, B.S. Pharm., clinical pharmacy manager, St. Mary’s of Michigan, Saginaw, Mich.
At the end of this presentation, participants should be able to outline appropriate symptomatic treatment for a patient with migraine headache; identify nondrug therapies for migraine headache; discuss over-the-counter therapy for a patient with migraine headache; and discuss appropriate preventative treatment for a patient with migraine headache. (This program meets requirements for obtaining pain management continuing education credit for pharmacists.)